【オープンパス公式YouTubeチャンネル相変わらずの「人気動画」ランキング上位動画①】不快感攻略セミナーPhaseⅡ（肩回りの筋膜リリース）にて、斎藤瑞穂講師が肩こりのテッパンリリース法である肩甲挙筋を狙った筋膜リリースのデモを行っています。 youtube.com/shorts/rSwm0pLRP…

肩甲挙筋を狙え！肩こりのテッパン筋膜リリース法（斎藤瑞穂） #shorts #筋膜リリース

■斎藤瑞穂ボディワーク・セッションのお申し込みはこちら↓からどうぞ。https://www.rolfingopenpath.com/...

youtube.com

DHA Islamabad- Rawalpindi

DHA Islamabad- Rawalpindi @DHAIR_Official

Jun 11

Register now for DHA's Summer Sports Camp 2026 before your young athlete misses their shot. Open to players under 18, it's the perfect place to train, compete and stay active all summer long. #DHAIR #PhaseII #SummerSportsCamp2026 #YouthSports #ActiveCommunity

Pam Farnsworth

Pam Farnsworth @kulawahine

Jun 11

No pension for riveter businesses? You gotta plan and set aside your own? I’m not really sure how much profit there was from the Windfarm? Recall? PhaseI sold power to MECO at 8-12cents/kWh? And PhaseII was subject to heavy curtailment?

Pam Farnsworth @kulawahine

Jun 11

They sold HHMI when Malabo Nui and First Wind sold the Windfarm? Mark John can live on easy street? Or that’s Dads retirement money? No more HHMI to pay for expensive dinners? And business trips?

kずお

kずお @aofukueng_ku

Jun 10

PhaseⅡ

161

佐藤雄二

佐藤雄二 @FormalyTwilter

Jun 9

$ARNA ダロバセルチブは、転移性ぶどう膜黒色腫を対象とした PhaseII/III OptimUM-02試験で主要評価項目を達成。 #ASCO2026 で発表された良好なデータは、プログラムのリスクを低減し、希少疾患に対するアプローチの有効性を裏付けている。 #Biotechnology #darovasertib #ダロバセルチブ ⬇️

catalystalert

@catalystalert

Jun 5

$ARNA darovasertib hits primary endpoint in Phase II/III OptimUM-02 for metastatic uveal melanoma. Positive data at ASCO 2026 de-risks program and validates approach in rare indication. 🔬 #biotech

Indian Pharma Post

Indian Pharma Post @indpharmapost

Jun 9

Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial indianpharmapost.com/rd/novo… #NovoNordisk #zenagamtide #type2 #diabetes #T2D #PhaseII #trial #diabetes @indpharmapost

Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial

Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions

indianpharmapost.com

ぁゎゎ

ぁゎゎ @P0852965

Jun 9

まだ分からない。医師が本当に使うのか、ガイドラインに入るのか、大学病院が積極採用するのかはこれからどうなるか。なので参考になるし正論だと思います。ただ株主･投資家として何を見てるかは、これ「将来の拡張性」例えば今のオンコリスには、食道がん（承認済）、胃がん PhaseⅡ、

1,464

Emerald Clinical

Emerald Clinical

@emeraldclinical

Jun 8

Rescued Phase II AML study — full‑service turnaround. Called in to salvage a small Phase II AML trial plagued by a non‑cooperative CRO, activation delays, low recruitment and sponsor turnover, we implemented an independent transition plan, weekly start‑up tracking, streamlined budgets, and focused site engagement (sponsor‑attended initiations, PI calls, targeted training). Result: smooth Phase I→II transition, restored timelines and budgets, improved enrollment and investigator morale. Read the case study: bit.ly/4dL51c1 #ScienceServiceSolutions #Oncology #AML #CRO #PhaseII

1:05